TY  - JOUR
AU  - Salwender, Hans
AU  - Weinhold, Niels
AU  - Benner, Axel
AU  - Miah, Kaya
AU  - Merz, Maximilian
AU  - Haenel, Mathias
AU  - Jehn, Christian
AU  - Mai, Elias
AU  - Menis, Ekaterina
AU  - Blau, Igor
AU  - Scheid, Christof
AU  - Hose, Dirk
AU  - Seckinger, Anja
AU  - Luntz, Steffen
AU  - Besemer, Britta
AU  - Munder, Markus
AU  - Brossart, Peter
AU  - Glass, Bertram
AU  - Lindemann, Hans-Walter
AU  - Weisel, Katja
AU  - Hanoun, Christine
AU  - Schnitzler, Paul
AU  - Klemm, Sarah
AU  - Goldschmidt, Hartmut
AU  - Raab, Marc
AU  - Elmaagacli, Ahmet
TI  - Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial.
JO  - Hematology
VL  - 29
IS  - 1
SN  - 1024-5332
CY  - Abingdon, Oxon
PB  - Taylor & Francis
M1  - DKFZ-2024-00434
SP  - 2320006
PY  - 2024
AB  - The seroprevalence of antibodies against Cytomegalovirus (CMV) is an established poor prognostic factor for patients receiving an allogeneic stem cell transplantation. However, the impact of CMV serology on outcome after autologous stem cell transplantation remains unknown.Here, we analyzed the CMV immunoglobulin (Ig) serology of 446 newly-diagnosed multiple myeloma (MM) patients of the GMMG-MM5 phase III trial with a median follow-up of 58 months.CMV IgG and IgM positivity was seen in 51
KW  - Humans
KW  - Cytomegalovirus
KW  - Hematopoietic Stem Cell Transplantation
KW  - Multiple Myeloma: diagnosis
KW  - Multiple Myeloma: therapy
KW  - Prevalence
KW  - Seroepidemiologic Studies
KW  - Transplantation, Autologous
KW  - Immunoglobulins, Intravenous
KW  - Antibodies, Viral
KW  - Immunoglobulin G
KW  - Cytomegalovirus Infections: epidemiology
KW  - Immunoglobulin M
KW  - CMV (Other)
KW  - CMV IgM (Other)
KW  - CMV-Infection (Other)
KW  - GMMG-MM5 Phase III Trial (Other)
KW  - age-depending effect (Other)
KW  - autologous stem cell transplantation (Other)
KW  - maintenance therapy (Other)
KW  - multiple myeloma (Other)
KW  - cytomegalovirus-specific hyperimmune globulin (NLM Chemicals)
KW  - Immunoglobulins, Intravenous (NLM Chemicals)
KW  - Antibodies, Viral (NLM Chemicals)
KW  - Immunoglobulin G (NLM Chemicals)
KW  - Immunoglobulin M (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:38407192
DO  - DOI:10.1080/16078454.2024.2320006
UR  - https://inrepo02.dkfz.de/record/288715
ER  -